Abstract #0231
Can MRI of the nigrosomes provide a biomarker for progression of Parkinsons Disease?
Stefan Schwarz 1 , Olivier Mougin 1 , Yue Xing 1 , Ania Blazejewska 1 , Lesley Martin 1 , Nin Bajaj 2 , Dorothee Auer 1 , and Penny Gowland 1
1
Sir Peter Mansfield Imaging Cetre,
University of Nottingham, Nottingham, Nottinghamshire,
United Kingdom,
2
Division
of Neurology, Nottingham University Hospitals NHS Trust,
Nottingham, Nottinghamshire, United Kingdom
Nigrosomes 1-5 can be detected at 7T and are less
visible in PD patients than in controls. The laterality
of loss of the nigrosomes correlates better with disease
laterality than DaTscan results for this group. The
variation in nigrosome visibility and nigrsome T2*w
signal with log(UPDRS) suggests that these measures may
provide a quantitative biomarker of PD progression.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
